Last 12 months
Inside the activity.
0 purchase rows · 457 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 47 |
| Dec 2025 | 0 | 21 |
| Jan 2026 | 0 | 41 |
| Feb 2026 | 0 | 21 |
| Mar 2026 | 0 | 54 |
| Apr 2026 | 0 | 29 |
| May 2026 | 0 | 33 |
| Jun 2026 | 0 | 68 |
| Jul 2026 | 0 | 47 |
| Aug 2026 | 0 | 33 |
| Sep 2026 | 0 | 59 |
| Oct 2026 | 0 | 4 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 29, 2024 Filed Mar 1, 2024 02:15 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 100 | $85.10 | $8,510.00 |
DisclosureSEC source: 0001415889-24-006005 · form4-02292024_090201.xml · nonDerivative · entry 5 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 224,644 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 02:15 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 20,526 | $9.29 | $190,686.54 |
DisclosureSEC source: 0001415889-24-006005 · form4-02292024_090201.xml · nonDerivative · entry 4 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 224,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 01:45 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 400 | $89.27 | $35,708.00 |
DisclosureSEC source: 0001415889-24-006199 · form4-03012024_080324.xml · nonDerivative · entry 6 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 463,585 F5 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. F9 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.86 to $89.62 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 01:45 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 701 | $87.61 | $61,417.13 |
DisclosureSEC source: 0001415889-24-006199 · form4-03012024_080324.xml · nonDerivative · entry 5 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 463,985 F5 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.38 to $88.03 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 01:45 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 4,933 | $86.63 | $427,352.20 |
DisclosureSEC source: 0001415889-24-006199 · form4-03012024_080324.xml · nonDerivative · entry 4 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 464,686 F5 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.23 to $87.1950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 01:45 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 3,966 | $85.47 | $338,955.78 |
DisclosureSEC source: 0001415889-24-006199 · form4-03012024_080324.xml · nonDerivative · entry 3 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 469,619 F5 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.17 to $85.73 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 01:45 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 3,000 | $90.01 | $270,036.00 |
DisclosureSEC source: 0001415889-24-006199 · form4-03012024_080324.xml · nonDerivative · entry 2 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: No plan indicated Ownership: Indirect · By Caraluna 2 Trust Disclosed balance after: 14,655 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.07 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 01:45 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 3,000 | $90.02 | $270,072.90 |
DisclosureSEC source: 0001415889-24-006199 · form4-03012024_080324.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: No plan indicated Ownership: Indirect · By Caraluna 1 Trust Disclosed balance after: 14,655 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.1750 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| February 29, 2024 Filed Mar 8, 2024 02:40 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
GrantCommon Stock | 3,607 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-007242 · form4-03072024_090304.xml · nonDerivative · entry 1 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,501 F1 · shares: On June 10, 2022, the Reporting Person was granted performance-based Restricted Stock Units (the "RSUs") covering 14,429 shares of Common Stock vesting in tranches upon the Issuer achieving certain specified financial and operating metrics. On February 29, 2024, the achievement of milestones for the vesting of RSUs covering 3,607 shares of Common Stock was certified. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| February 29, 2024 Filed Mar 8, 2024 02:40 UTC |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
|
GrantCommon Stock | 3,206 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-007243 · form4-03072024_090309.xml · nonDerivative · entry 1 Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,512 F1 · shares: On June 10, 2022, the Reporting Person was granted performance-based Restricted Stock Units (the "RSUs") covering 12,826 shares of Common Stock vesting in tranches upon the Issuer achieving certain specified financial and operating metrics. On February 29, 2024, the achievement of milestones for the vesting of RSUs covering 3,206 shares of Common Stock was certified. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| February 27, 2024 Filed Mar 1, 2024 02:15 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,807 | $0.00 Strike: $9.29 | $0.00 |
DisclosureSEC source: 0001415889-24-006005 · form4-02292024_090201.xml · derivative · entry 10 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,526 Underlying: Common Stock · 7,807 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| February 27, 2024 Filed Mar 1, 2024 02:15 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 27,500 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0001415889-24-006005 · form4-02292024_090201.xml · derivative · entry 9 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,500 shares Expires 2027-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| February 27, 2024 Filed Mar 1, 2024 02:15 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 35,307 | $75.09 | $2,651,297.96 |
DisclosureSEC source: 0001415889-24-006005 · form4-02292024_090201.xml · nonDerivative · entry 3 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 204,218 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 27, 2024 Filed Mar 1, 2024 02:15 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 7,807 | $9.29 | $72,527.03 |
DisclosureSEC source: 0001415889-24-006005 · form4-02292024_090201.xml · nonDerivative · entry 2 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 239,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2024 Filed Mar 1, 2024 02:15 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 27,500 | $10.41 | $286,275.00 |
DisclosureSEC source: 0001415889-24-006005 · form4-02292024_090201.xml · nonDerivative · entry 1 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 231,718 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2024 Filed Feb 24, 2024 02:40 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
Exercise / conversionStock Option (right to buy) · Derivative | 380,036 | $0.00 Strike: $2.66 | $0.00 |
DisclosureSEC source: 0001415889-24-005160 · form4-02232024_090202.xml · derivative · entry 3 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · RMDM Trust Disclosed balance after: 0 Underlying: Common Stock · 380,036 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The Reporting Person exercised this option as required prior to the expiration date of February 24, 2024. F3 · derivative.exercise_date: The option shares are fully exercisable. F2 · derivative.underlying_shares: The Reporting Person exercised this option as required prior to the expiration date of February 24, 2024. F1 · ownership.nature: The RMDM Trust is an irrevocable spendthrift trust for the benefit of the Reporting Person and other discretionary beneficiaries, pursuant to Nevada Revised Statutes Chapter 166. Under the RMDM Trust, the Reporting Person has no enforceable rights to distributions. The RMDM Trust is a fully discretionary trust and the distribution decisions for the RMDM Trust are vested in a committee. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| February 23, 2024 Filed Feb 24, 2024 02:40 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
Exercise / conversionCommon Stock | 380,036 | $2.66 | $1,009,717.65 |
DisclosureSEC source: 0001415889-24-005160 · form4-02232024_090202.xml · nonDerivative · entry 1 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · RMDM Trust Disclosed balance after: 1,050,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The RMDM Trust is an irrevocable spendthrift trust for the benefit of the Reporting Person and other discretionary beneficiaries, pursuant to Nevada Revised Statutes Chapter 166. Under the RMDM Trust, the Reporting Person has no enforceable rights to distributions. The RMDM Trust is a fully discretionary trust and the distribution decisions for the RMDM Trust are vested in a committee. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| February 16, 2024 Filed Feb 17, 2024 02:45 UTC |
ROSENMAN HERMDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 93,901 | $0.00 Strike: $2.66 | $0.00 |
DisclosureSEC source: 0001415889-24-004268 · form4-02172024_020201.xml · derivative · entry 4 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 93,901 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: The Reporting Person exercised this option as required prior to the expiration date of February 24, 2024. F5 · derivative.exercise_date: The option shares are fully exercisable. F4 · derivative.underlying_shares: The Reporting Person exercised this option as required prior to the expiration date of February 24, 2024. Read SEC document |
| February 16, 2024 Filed Feb 17, 2024 02:45 UTC |
ROSENMAN HERMDirector
|
SaleCommon Stock | 35,947 | $69.85 | $2,510,851.22 |
DisclosureSEC source: 0001415889-24-004268 · form4-02172024_020201.xml · nonDerivative · entry 3 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,685 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.53 to $70.12 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 17, 2024 02:45 UTC |
ROSENMAN HERMDirector
|
SaleCommon Stock | 57,954 | $69.08 | $4,003,520.27 |
DisclosureSEC source: 0001415889-24-004268 · form4-02172024_020201.xml · nonDerivative · entry 2 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,632 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.5270 to $69.36 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 17, 2024 02:45 UTC |
ROSENMAN HERMDirector
|
Exercise / conversionCommon Stock | 93,901 | $2.66 | $249,485.57 |
DisclosureSEC source: 0001415889-24-004268 · form4-02172024_020201.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 02:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 5,000 | $70.10 | $350,486.00 |
DisclosureSEC source: 0001415889-24-003123 · form4-02082024_090202.xml · nonDerivative · entry 5 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 473,585 F5 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.87 to $70.33 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 02:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 500 | $70.10 | $35,048.75 |
DisclosureSEC source: 0001415889-24-003123 · form4-02082024_090202.xml · nonDerivative · entry 4 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Indirect · By Caraluna 2 Trust Disclosed balance after: 17,655 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.96 to $70.33 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 02:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 500 | $70.10 | $35,050.45 |
DisclosureSEC source: 0001415889-24-003123 · form4-02082024_090202.xml · nonDerivative · entry 2 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Indirect · By Caraluna 1 Trust Disclosed balance after: 17,655 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.96 to $70.33 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| February 06, 2024 Filed Feb 9, 2024 02:40 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 23,959 | $0.00 Strike: $19.68 | $0.00 |
DisclosureSEC source: 0001415889-24-003124 · form4-02082024_090202.xml · derivative · entry 5 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,959 shares Expires 2029-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| February 06, 2024 Filed Feb 9, 2024 02:40 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,070 | $0.00 Strike: $9.29 | $0.00 |
DisclosureSEC source: 0001415889-24-003124 · form4-02082024_090202.xml · derivative · entry 4 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,070 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| February 06, 2024 Filed Feb 9, 2024 02:40 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 34,029 | $70.03 | $2,383,129.14 |
DisclosureSEC source: 0001415889-24-003124 · form4-02082024_090202.xml · nonDerivative · entry 3 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,646 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.22 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 06, 2024 Filed Feb 9, 2024 02:40 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 23,959 | $19.68 | $471,513.12 |
DisclosureSEC source: 0001415889-24-003124 · form4-02082024_090202.xml · nonDerivative · entry 2 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2024 Filed Feb 9, 2024 02:40 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 10,070 | $9.29 | $93,550.30 |
DisclosureSEC source: 0001415889-24-003124 · form4-02082024_090202.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2024 Filed Feb 9, 2024 02:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 3,000 | $70.00 | $210,006.30 |
DisclosureSEC source: 0001415889-24-003123 · form4-02082024_090202.xml · nonDerivative · entry 3 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Indirect · By Caraluna 2 Trust Disclosed balance after: 18,155 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.02 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| February 06, 2024 Filed Feb 9, 2024 02:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 3,000 | $70.00 | $210,004.80 |
DisclosureSEC source: 0001415889-24-003123 · form4-02082024_090202.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Indirect · By Caraluna 1 Trust Disclosed balance after: 18,155 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.02 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| February 01, 2024 Filed Feb 3, 2024 02:40 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 22,281 | $67.73 | $1,509,080.99 |
DisclosureSEC source: 0001415889-24-002413 · form4-02022024_090201.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,646 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2022. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 01:57 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
SaleCommon Stock | 2,358 | $65.09 | $153,484.81 |
DisclosureSEC source: 0001415889-24-002015 · form4-01312024_010143.xml · nonDerivative · entry 2 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,494 F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 02:02 UTC |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
|
SaleCommon Stock | 3,426 | $65.09 | $223,002.11 |
DisclosureSEC source: 0001415889-24-002018 · form4-01312024_020131.xml · nonDerivative · entry 2 Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,977 F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 02:05 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 14,813 | $65.09 | $964,194.46 |
DisclosureSEC source: 0001415889-24-002019 · form4-01302024_090101.xml · nonDerivative · entry 2 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246,957 F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 02:15 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 3,235 | $65.09 | $210,569.71 |
DisclosureSEC source: 0001415889-24-002022 · form4-01302024_090101.xml · nonDerivative · entry 2 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,927 F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 02:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 546 | $65.09 | $35,539.74 |
DisclosureSEC source: 0001415889-24-002021 · form4-01302024_090104.xml · nonDerivative · entry 2 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 478,585 F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 02:05 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 4,265 | $65.09 | $277,613.54 |
DisclosureSEC source: 0001415889-24-002020 · form4-01302024_090101.xml · nonDerivative · entry 2 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,218 F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 01:57 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
GrantCommon Stock | 31,352 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-002015 · form4-01312024_010143.xml · nonDerivative · entry 1 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,852 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on January 26, 2025 and the remaining RSUs vest in 12 equal quarterly installments thereafter. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 02:02 UTC |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
|
GrantCommon Stock | 31,352 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-002018 · form4-01312024_020131.xml · nonDerivative · entry 1 Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,403 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on January 26, 2025 and the remaining RSUs vest in 12 equal quarterly installments thereafter. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 02:05 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
GrantCommon Stock | 86,220 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-002019 · form4-01302024_090101.xml · nonDerivative · entry 1 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,770 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on January 26, 2025 and the remaining RSUs vest in 12 equal quarterly installments thereafter. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 02:15 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 31,352 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-002022 · form4-01302024_090101.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,162 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on January 26, 2025 and the remaining RSUs vest in 12 equal quarterly installments thereafter. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 20:05 UTC |
HEALY JAMESDirector
|
GrantCommon Stock | 264 | $63.79 | $16,840.56 |
DisclosureSEC source: 0001415889-24-002000 · form4-01302024_080104.xml · nonDerivative · entry 1 HEALY JAMES · CIK 0001245624 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,500 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $16,875 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 01:05 UTC |
ROSENMAN HERMDirector
|
GrantCommon Stock | 303 | $63.79 | $19,328.37 |
DisclosureSEC source: 0001415889-24-002001 · form4-01302024_080109.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,685 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $19,375 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
GrantCommon Stock | 352 | $63.79 | $22,454.08 |
DisclosureSEC source: 0001415889-24-001999 · form4-01302024_080103.xml · nonDerivative · entry 1 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $22,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 02:27 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
GrantCommon Stock | 68,976 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-002024 · form4-01312024_020107.xml · nonDerivative · entry 5 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,072,556 F5 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on January 26, 2025 and the remaining RSUs vest in 12 equal quarterly installments thereafter. F6 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 02:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
GrantCommon Stock | 9,405 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-002021 · form4-01302024_090104.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479,131 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on January 26, 2025 and the remaining RSUs vest in 12 equal quarterly installments thereafter. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 02:05 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
GrantCommon Stock | 27,433 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-002020 · form4-01302024_090101.xml · nonDerivative · entry 1 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,483 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on January 26, 2025 and the remaining RSUs vest in 12 equal quarterly installments thereafter. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 01:05 UTC |
Baynes Roy D.Director
|
GrantCommon Stock | 215 | $63.79 | $13,714.85 |
DisclosureSEC source: 0001415889-24-001998 · form4-01302024_080101.xml · nonDerivative · entry 1 Baynes Roy D. · CIK 0001680739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,407 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $13,750 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 24, 2024 Filed Jan 27, 2024 02:40 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 944 | $67.00 | $63,248.00 |
DisclosureSEC source: 0001415889-24-001895 · form4-01262024_090101.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,810 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.